IDH1 Peptide Vaccine for Recurrent Grade II Glioma

NCT02193347 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Brain Cancer
Brain Neoplasm, Primary
Brain Neoplasms, Recurrent
Brain Tumor
Cancer of the Brain

Interventions

BIOLOGICAL: PEPIDH1M vaccine
BIOLOGICAL: Tetanus-Diphtheria Toxoid (Td)
DRUG: Temozolomide

Sponsor

Katy Peters, MD, PhD